All Articles

Longevity Clinical Trial Launches For Dogs

October 29, 2023
x min read

Longevity biotech is all the rage in Silicon Valley for human health. And now there’s a clinical trial with a new twist: longevity science for dogs.

What’s happening:

  • Silicon Valley based startup Loyal is launching a clinical trial to validate their therapeutic drug for extending dog’s lifespan
  • The new clinical trial is widely seen as the largest clinical trial ever for veterinary medicine
  • Loyal has notable backers such as Khosla Ventures, First Round Capital, Box Group, Collaborative Fund, The Longevity Fund and others

Why it matters:

  • There have been very few meaningful breakthroughs in the science around helping animals live longer and extend lifespan
  • If Loyal is able to successful win FDA approval they would become the first ever startup to have a prescription medication for extending dog’s lifespan and overall quality of mobility and health

By the numbers:

  • Over 1,000 dogs will receive the drug manufactured by Loyal, which will be disguised inside of a treat

The intrigue:

  • Loyal is keeping the specifics around their drug and how it works a closely guarded secret until the completion of the clinical trial

Going deeper:

  • If the clinical trial proves successful Loyal believes it could have major implications for the health of human beings as well

Discover what’s next. The world’s biggest ideas, disruptive trends, most exciting early stage companies and groundbreaking entrepreneurs.

By clicking Subscribe you're confirming that you agree with our Privacy Policy.
Thanks for subscribing!
Keep an eye out for a welcome email shortly.
Oops! Something went wrong while submitting the form.